Therapeutic Goods Labelling Exemption 2026

I, Anthony Lawler, as the appropriate authority, grant the following labelling exemption.

Dated 9 October 2026

Professor Anthony Lawler

Deputy Secretary

Health Products Regulation Group

Department of Health, Disability and Ageing

1 Name

This instrument is the Therapeutic Goods (Poisons Standard) (COVID-19 Vaccine-Pfizer) (SARS-CoV-2 Spike Protein (mRNA) XFG) Labelling Exemption 2026.

2 Commencement

(1) Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

Note: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.

(2) Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.

3 Authority

This instrument is made under section 39 of the current Poisons Standard.

4 Definitions

Note 1: A number of expressions used in this instrument are defined in subsection 3(1) of the Act, including the following:

1. current Poisons Standard;